Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

38.1K
Overview
38.1K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

14.8K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

6.3K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
6.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Mismatch Repair01:20

Mismatch Repair

5.4K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Critical reagents for ligand-binding assays: process development methodologies to enable high-quality reagents.

Bioanalysis·2022
Same author

Confirmatory cut point has limited ability to make accurate classifications in immunogenicity assays.

Bioanalysis·2020
Same author

Storage Conditions of Conjugated Reagents Can Impact Results of Immunogenicity Assays.

Journal of immunology research·2016
See all related articles

Related Experiment Video

Updated: May 3, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K

Cut Point in Immunogenicity Testing: A Flawed Concept We Can Live Without.

Robert J Kubiak1

  • 1Bioanalytical Science, Third Arc Bio Inc., 727 Norristown Road, Bldg 8, Suite 320, 19002, Lower Gwynedd, Pennsylvania, USA. Robert@ThirdArcBio.com.

The AAPS Journal
|October 6, 2025
PubMed
Summary

The current method for detecting anti-drug antibodies (ADA) using cut points is flawed. A new approach focusing on post-baseline changes is proposed to improve accuracy and reduce lab workload.

Keywords:
anti-drug antibodies (ADA)cut pointimmunogenicity

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.3K

Related Experiment Videos

Last Updated: May 3, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

10.3K

Area of Science:

  • Immunology
  • Bioanalytical Chemistry
  • Pharmacology

Background:

  • The standard method for anti-drug antibody (ADA) detection uses a tiered strategy with statistical cut points for classification.
  • This approach compares individual responses to a population-based threshold, aiming for high sensitivity and specificity.

Purpose of the Study:

  • To critically evaluate the scientific validity of using cut points in ADA detection.
  • To propose an alternative, more reliable method for ADA classification.

Main Methods:

  • Analysis of the statistical and experimental limitations of current ADA cut point determination.
  • Proposal of a new detection strategy based on post-baseline signal changes and their correlation with clinical parameters.

Main Results:

  • Cut points, particularly those at the 95th percentile, do not effectively reduce false negatives and may hinder ADA detection in a significant portion of the population.
  • Discrepancies between conditions for cut point determination and actual sample testing compromise reliability.

Conclusions:

  • The use of cut points and tiered testing strategies for ADA classification is scientifically flawed and should be abandoned.
  • Adopting a method that analyzes post-baseline signal changes relative to pharmacokinetics, pharmacodynamics, efficacy, and safety will improve ADA detection and reduce laboratory workload.